Skip to main content
Access IndiaPLATFORM
HomeHSNChapter 12HSN 1211 90 43

Ipecac dried rhizome and roots

Ipecac dried rhizome and roots for pharmaceutical or medicinal use

NO PGA · STANDARD CUSTOMS PROCEDURE

HSN 1211 90 43 (Ipecac dried rhizome and roots) is not covered by a Bureau of Indian Standards Quality Control Order and carries no Partner Government Agency clearance requirement at the tariff-line level. Import follows the standard customs procedure: Importer-Exporter Code (IEC), bill of entry, commercial invoice, packing list. Other medicinal plant material in Chapter 12 — particularly material destined for pharmaceutical manufacture or classified in a more processed form — may attract oversight from drug-regulatory authorities at the chapter or end-use level.

No partner government agency notification covers this tariff line.
A word of counsel

Although this tariff line carries no product-specific compliance, ipecac is a pharmacologically active botanical with a documented regulatory history in India's drug control framework; importers should confirm that the end-use application does not independently trigger licensing under drugs and cosmetics legislation. Re-classification by customs — for instance, to a processed extract or a finished pharmaceutical preparation — would retrospectively impose the compliance regime applicable to that line, including detention pending the relevant licence. Verify the product's physical form, processing state, and intended use against the customs tariff before relying on the absence of compliance here.

Need a regulatory steer on this product?
Speak to a regulatory counsel about your specific HSN, IS, and supplier situation.
Speak to an Expert
Frequently asked
Does HSN 1211 90 43 require any pre-import registration?
A valid Importer-Exporter Code is required for any commercial import; no product-specific registration applies to this tariff line.
What changes if the ipecac is imported as a processed extract or finished preparation rather than dried rhizome and roots?
Processed extracts and finished pharmaceutical preparations are classified outside Chapter 12 and may attract drug-regulatory compliance, including import licensing requirements applicable to that tariff line.
Last verified against gazette notifications: 2026-05-16. Source: BIS / DGFT / Indian Customs CUSDATA.
Related